CytoPep

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCytoPep
Drug Alias NameNPY1 receptor based peptide-drug conjugate (OntoChem)anticancer therapeutics (OntoChem/University of Leipzig)OC-528
ClassificationBiologics
Mechanisms of ActionNeuropeptide Y receptor type 1 modulators
TargetsNeuropeptide Y receptor type 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOntoChem GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOntoChem GmbHTube Pharmaceuticals GmbHLeipzig University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A